A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors

In recent years, human serum albumin (HSA) has been characterized as an ideal drug carrier in the cancer arena. Caveolin-1 (Cav-1) has been established as the principal structural protein of caveolae and, thus, critical for caveolae-mediated endocytosis. Cav-1 has been shown to be overexpressed in c...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ryan Robb, Jimmy Chun-Tien Kuo, Yang Liu, Sergio Corrales-Guerrero, Tiantian Cui, Ahmad Hegazi, Gregory Nagy, Robert J. Lee, Terence M. Williams
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2021-09-01
Saila:	Molecular Therapy: Oncolytics
Gaiak:	SSH20 lung cancer pancreatic cancer caveolin-1 albumin SN-38
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2372770521001108
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!